Gastrointestinal tract bleeding associated with naproxen sodium vs ibuprofen

Archives of Internal Medicine

Volumn 157, Issue 22, 1997, Pages 2626-2631

  Strom, Brian L ^a   Schinnar, Rita ^a   Bilker, Warren B ^a   Feldman, Harold ^a   Farrar, John T ^a   Carson, Jeffrey L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Department of Pediatrics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; NAPROXEN;

ADOLESCENT; ADULT; AGED; ARTHRITIS; ARTHROPATHY; ARTICLE; CHILD; DATA ANALYSIS; DRUG MONITORING; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030726267     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.22.2626     Document Type: Article

References (17)

1. Carson JL, Strom BL Medicaid databases. In: Strom BL, ed. Pharmacoepidemiology. New York, NY: John Wiley & Sons Inc; 1994:199-216.
2. Strom BL, Carson JL, Morse ML, Le Roy AA. The computerized on-line Medicaid pharmaceutical analysis and surveillance system: a new resource for postmarketing drug surveillance. Clin Pharmacol Ther. 1985;38:359-364.
3. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
4. Preston DL, Lublin JH, Pierce DA, McConney ME. Epicure. Seattle, Wash: Microsoft International Software; 1993:175-185.
5. Prentice RL, A case-cohort design for epidemiology cohort studies and disease prevention trials. Biometrics. 1986;73:1-11.
6. Suissa S, Novel approaches to pharmacoepidemiology study design and statistical analysis. In: Strom BL, ed. Pharmacoepidemiology. New York, NY: John Wiley & Sons Inc; 1994:629-644.
7. Kleinbaum DG, Kupper LL, Morgenstern H. Statistical inference about effect measure: simple analysis. In: Epidemiologic Research: Principles and Quantitative Methods. London, England: Lifetime Learning Publications; 1982:284-311.
8. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol, 1989;129:125-137.
9. Carson JL, Strom BL, West SL, Morse SL. The association of nonsteroidal antiinflammatory drugs with upper gastrointestinal tract bleeding. Arch intern Med. 1987;147:85-88.
10. Cutler JA, Mendeioff AI. Upper gastrointestinal bleeding: nature and magnitude of the problem in the US. Dig Dis Sci 1981;26(suppl):90S-96S.
11. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986;1:462-464.
12. Carson JL, Strom BL, Morse ML, et al. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch intern Med. 1987:147:1054-1059.
13. Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding, Clin Pharmacol Ther. 1993;53:485-494.
14. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology. 1993;105:1078-1088.
15. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:769-772.
16. Langman MJ, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:1075-1078.
17. Henry D, Lim LL-Y, Garcia Rodriguez LA, et al. Variability in risk of upper gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ. 1996;312:1563-1566.